Close Menu

    Subscribe to Updates

    Get the latest creative news from FooBar about art, design and business.

    What's Hot

    Here are some reasons why this unpopular stock market technique might work now that trade agreements are being finalized.

    May 12, 2025

    How Bessent clarified the euphoric market reaction to the 115-point drop in U.S.-China tariffs

    May 12, 2025

    This is the difference in weight loss between Zepbound and Wegovy.

    May 12, 2025
    Facebook X (Twitter) Instagram
    🔴
    Trending
    • Here are some reasons why this unpopular stock market technique might work now that trade agreements are being finalized.
    • How Bessent clarified the euphoric market reaction to the 115-point drop in U.S.-China tariffs
    • This is the difference in weight loss between Zepbound and Wegovy.
    • Trump’s announcement that he will issue an executive order to reduce the cost of prescription drugs has put pressure on pharmaceutical stocks.
    • This week marks the release of the “most important consumer earnings report of the season.”
    • Goldman Sachs warns that stocks might collapse by about 20%. This is the trigger.
    • The majority of American businesses may be impacted by Trump’s proposal to raise taxes on affluent Americans.
    • Even if the trade conflict fades, Hartnett of Bank of America remains concerned about stocks at the start of the year.
    BourseWatch – Latest Daily Stock Market And Finance NewsBourseWatch – Latest Daily Stock Market And Finance News
    • HOME
    • TOOLS
      • CURRENCY CONVERTER
      • RANKING TABLE
      • STOCK SCREENER
      • FOREX HEATMAP
      • ECONOMIC CALENDER
      • REAL-TIME CHART
      • FOREX SUMMARY
    • MARKET
      1. COMMODITIES
      2. REAL ESTATE
      3. CRYPTO CURRENCIES
      4. CURRENCY / FOREX
      5. ETF / RTF
      6. EQUITIES
      7. INDEXES
      8. View All

      Oil Approaches $80 a Barrel Amid Market Strength Indicators

      March 3, 2025

      Gold may surpass $3,000, but you’re overpaying at these prices.

      February 21, 2025

      In September’s Commodities Rise, Silver Stands Out as the Big Winner

      September 29, 2024

      Gold is “a hedge against everything that could happen next.” A Fed ruling is coming up

      September 14, 2024

      Purchasing a home without a home appraisal? Start by reading this.

      May 7, 2025

      As homeowners find it difficult to sell, the housing market stagnates: “We’re really bleeding.”

      April 25, 2025

      Due to the numerous economic uncertainties they face, distressed homebuyers are leaving the real estate market.

      April 25, 2025

      Three dubious strategies from the 2008 housing crisis may be returning.

      April 16, 2025

      Coinbase expects lower subscription revenue. A lot more went wrong for the crypto exchange.

      May 9, 2025

      Bitcoin and stocks rise together to reach $100,000 once more as market euphoria returns.

      May 9, 2025

      Ether and Bitcoin are rising. MicroStrategy, China Trade Hope, and Other Factors Influencing Cryptocurrencies.

      May 1, 2025

      FTX Liquidates Cryptocurrency Holdings to Settle Debts and Reimburse Customers Amid Ongoing Legal Battles

      April 6, 2025

      According to a Goldman research, this is the point at which the 10-year Treasury yield poses a “clear problem” for equities.

      May 3, 2024

      These ETFs guard against “black swan” stock market events, such as the one we just witnessed.

      April 3, 2025

      The Muni market is “shifting in favor of ETFs.” What yields and hazards are involved?

      February 19, 2025

      The S&P 500 has too many tech stocks. This different ETF keeps beating it.

      October 6, 2024

      This way of investing in dividend stocks can help you spread out your exposure to S&P 500 index funds.

      August 30, 2024

      Challenges for Tech Giants: Microsoft, Google, and AMD Stocks Take a Hit Despite Strong Earnings

      June 22, 2024

      ECB’s Villeroy Affirms: Oil Uncertainty No Barrier to June Rate Cut

      April 29, 2024

      Federal Reserve’s Move Leaves Regional Banks in a Quandary for 2024

      April 29, 2024

      Israel’s Credit Rating Takes a Dive: S&P Warns of Military Escalation with Iran

      April 29, 2024

      Here are some reasons why this unpopular stock market technique might work now that trade agreements are being finalized.

      May 12, 2025

      How Bessent clarified the euphoric market reaction to the 115-point drop in U.S.-China tariffs

      May 12, 2025

      Goldman Sachs warns that stocks might collapse by about 20%. This is the trigger.

      May 9, 2025

      The majority of American businesses may be impacted by Trump’s proposal to raise taxes on affluent Americans.

      May 9, 2025
    • ECONOMY
      1. INTEREST RATE
      2. View All

      A watchdog group says the IRS has only made “limited progress” in figuring out how often people making less than $400,000 are audited.

      September 3, 2024

      There is a “ticking tax time bomb” in your 401(k) and IRA. An expert says you should go all-in on Roths instead.

      August 21, 2024

      Like Trump, Kamala Harris wants to keep tip taxes low. Some people think the idea is “very silly,” and it doesn’t matter who comes up with it.

      August 19, 2024

      When Is the Best Time to Change a Roth IRA? Make the Most of This Tax-Smart Move

      August 12, 2024

      Trump’s announcement that he will issue an executive order to reduce the cost of prescription drugs has put pressure on pharmaceutical stocks.

      May 12, 2025

      Trump frequently refers to unilateral “deals.” A Goldman economist cautions that some tariffs might increase.

      May 9, 2025

      The U.S. goods trade gap reaches a record high as companies try to evade Trump’s tariffs.

      April 30, 2025

      Canadian Musicians Face U.S. Tour Challenges in Trump Era

      April 30, 2025
    • NEWS
      1. ALL NEWS
      2. COMPANIES
      3. CURRENCY FOREX
      4. INDEXES
      5. View All

      Trump’s 10% Tariff Plan Echoes Nixon’s 1971 Strategy: A Closer Look at the Historical Precedent

      April 6, 2025

      Groundbreaking Partnership: Iranian President Ebrahim Raisi Unveils Revolutionary Hydropower and Irrigation Venture in Sri Lanka

      April 2, 2025

      Binance Bombshell: Founder Faces 36 Months in U.S. Jail for Money Laundering Violations

      April 2, 2025

      Polestar’s Strategic Shift: US Plant to Supply Europe Amid Escalating EU-China Strife

      April 2, 2025

      This is the difference in weight loss between Zepbound and Wegovy.

      May 12, 2025

      This week marks the release of the “most important consumer earnings report of the season.”

      May 12, 2025

      That large order for a Boeing aircraft? 32 of its aircraft have been ordered by IAG, the operator of British Airways.

      May 9, 2025

      Would video game developers be impacted by a Trump tariff on films made abroad?

      May 7, 2025

      China Securities Regulator Halts Restricted Share Lending in Move to Stabilize Stock Markets

      August 14, 2024

      Global Markets Wobble as China’s Evergrande Faces Liquidation, Federal Reserve Meeting Looms

      June 22, 2024

      China’s Stock Slump and Currency Plunge Cloud Asia’s Rate Cut Optimism

      March 22, 2024

      Mexican Peso Ascends to Unprecedented Heights, Instilling Fear in Investors

      March 15, 2024

      Traders Anticipate ‘Once-in-a-Generation’ Opportunity in Emerging Markets as Federal Reserve Hints at Rate Cuts

      April 6, 2025

      LSEG Shareholders Face Showdown: Vote on Doubling CEO’s Potential Pay

      April 2, 2025

      Critical Week for Stock Market as $10 Trillion in Big Tech Earnings Shape S&P 500’s Fate

      March 2, 2025

      Asian Markets Surge Despite Global Uncertainties; Beijing’s Stimulus Measures Boost Investor Confidence

      March 2, 2025

      This is the difference in weight loss between Zepbound and Wegovy.

      May 12, 2025

      This week marks the release of the “most important consumer earnings report of the season.”

      May 12, 2025

      That large order for a Boeing aircraft? 32 of its aircraft have been ordered by IAG, the operator of British Airways.

      May 9, 2025

      People are delaying their travel plans till the very last minute. Here are some examples of when it can work and when it can go wrong.

      May 9, 2025
    • LIST & RANKING

      The force behind the recent surge in stocks is Big Tech, not the Fed. What investors should know is as follows.

      June 16, 2024

      Top 25 Independent Advisors

      February 27, 2024

      Top CEO’s of the Year

      January 18, 2024

      The Best Online Brokers

      January 18, 2024

      The Most Profitable Businesses

      January 18, 2024
    Donate
    BourseWatch – Latest Daily Stock Market And Finance NewsBourseWatch – Latest Daily Stock Market And Finance News
    Home » Qualcomm and Arm are going to court today. How the longtime chip partners ended up in court.
    News

    Qualcomm and Arm are going to court today. How the longtime chip partners ended up in court.

    December 16, 2024No Comments
    Facebook Twitter Pinterest LinkedIn WhatsApp Reddit Tumblr Email
    im 67012517
    Share
    Facebook Twitter LinkedIn Pinterest Email

    Arm ARM 4.09% Holdings and Qualcomm QCOM -2.44% will go to court in Delaware on Monday morning to fight. They are both friends and competitors. Both companies and the chip ecosystem as a whole have a lot riding on the result of the trial.

    Arm designs are the basis for some of Qualcomm’s most important chips, like the processors that run phones, PCs, cars, and applications that connect things to the internet. Charles Shi, a researcher at Needham, says that Qualcomm made up 10% of Arm’s income in fiscal year 2024.

    Arm and Qualcomm stock prices were both going down on Monday morning, by 4% and 2.2%, respectively.

    How did it happen that these partners were in court?

    In the beginning of this story, more than ten years ago, Qualcomm tried to copy Apple AAPL +0.33% by making its own chips. Apple had shown that custom processor cores were the best way to get better speed and use less power. They did this by building on the technology that Arm licenses.

    Qualcomm tried many times to catch up to Apple but failed. Apple got more chips, which made its iPhones, Macs, and iPads faster and gave them longer battery lives.

    Gerard Williams III, Apple’s top chip creator, was one of the people who gave the company an edge. With experts from Google, Williams left Apple in 2019 to start a new company called Nuvia.

    Even though Nuvia never put out a product, in August 2020 it published a white paper on its new Arm-based custom CPU cores. This got a lot of attention in the chip design community, including at Qualcomm, which saw the start-up as a way to speed up its customization efforts.

    It cost $1.4 billion for Qualcomm to buy Nuvia in 2021. Williams was made Senior Vice President of Engineering at Qualcomm, a job he still has today.

    The first things that Qualcomm revealed came from their purchase of Nuvia in 2024: chips for high-end smartphones, AI PCs, and cars. The new Oryon CPU cores that came with Nuvia are in all of them, and some users already have these chips.

    But Arm is pushing back because all of these tailored chips are still based on its designs. It thinks that Nuvia giving Qualcomm intellectual property is against the terms of its license deals with both companies. Arm says that the Nuvia technology is tied to Nuvia’s license and can’t be given to someone else. It wants the court to order Qualcomm to get rid of all the intellectual property that came with Nuvia. This IP is used in some of Qualcomm’s most important chips today.

    Qualcomm says that the Nuvia technology is covered by its own Arm license.

    Before the trial, both businesses said they were sure of their cases.

    In Judge Maryellen Noreika’s “rocket docket,” the hearing starts Monday and will last for a week. There will be 11 hours for each side to make their case.

    There is a lot at stake for Qualcomm. If it lost, it would have to talk about a new license deal, and Arm would be able to get what it wants. The cost of its license could go up a lot, which would cut into profits. Since Arm first sued in 2022, Qualcomm shares have gone down 17%.

    Arm, which has been called the “Switzerland of Tech” for a long time, may be trying something new with this study. Anyone can get a license to use its technology, and it doesn’t go up against clients. That approach helped Arm build an ecosystem with 300 billion chips over the years. Arm makes parts for almost all smartphones.

    It has been more aggressive since Rene Haas became CEO in 2022. For example, it sued one of its best users and raised prices for new technology by twice as much. Talks also say that Arm and SoftBank 9984 +0.99%, which owns a lot of the company, are making AI chips that will fight with its customers for the first time.

    A loss in court could make Haas change his mind about Arm’s position.

    When other Arm customers see this legal fight, they might start to think about other ways to design their chips in the future.

    RISC-V is an open-source technology that can be used and changed by anyone for free. Over time, chip designs that use RISC-V could become a real threat to the Arm environment.

    Qualcomm has already set up a business partnership in Europe to make RISC-V chips for cars. Nvidia NVDA -1.82% said at the recent RISC-V Summit that RISC-V is used in many of its products. RISC-V is also used in Google’s own AI chip, the TPU.

    At the same time, China, which gave Arm 21% of its revenue last fiscal year, wants to rely less on Western technology. RISC-V is being used by a lot of Chinese chip makers.

    If Arm plays its hand too safe, even a win at trial could turn into a long-term loss, which would change the way chips are made.

    Both Qualcomm and Arm have strong reasons to settle the dispute, but they have both taken very strong stances. The document at the center of the fight, Qualcomm’s Arm license, has never been made public, so it’s impossible to even guess what will happen.

    That being said, investors and everyone else in the chip world will wait for this week’s hearing.

    Share. Facebook Twitter Pinterest LinkedIn Tumblr Telegram Email

    Related Posts

    This is the difference in weight loss between Zepbound and Wegovy.

    May 12, 2025

    This week marks the release of the “most important consumer earnings report of the season.”

    May 12, 2025

    That large order for a Boeing aircraft? 32 of its aircraft have been ordered by IAG, the operator of British Airways.

    May 9, 2025
    Leave A Reply Cancel Reply

    Top Posts

    Aeries Technology: A Global Professional Services Leader in Business Transformation

    June 10, 2024

    As Christmas sales break records, stock buybacks soar.

    December 5, 2024

    These other stocks, along with Coinbase and Block, could join the S&P 500 in the next shake-up.

    December 6, 2024

    Why Powell and the Fed should stop lowering interest rates in December

    December 7, 2024
    Don't Miss
    Market

    Here are some reasons why this unpopular stock market technique might work now that trade agreements are being finalized.

    May 12, 2025

    levies between the United States and China were both significantly reduced about a month after…

    How Bessent clarified the euphoric market reaction to the 115-point drop in U.S.-China tariffs

    May 12, 2025

    This is the difference in weight loss between Zepbound and Wegovy.

    May 12, 2025

    Trump’s announcement that he will issue an executive order to reduce the cost of prescription drugs has put pressure on pharmaceutical stocks.

    May 12, 2025
    Stay In Touch
    • Facebook
    • Instagram

    Subscribe to Updates

    Get the latest Update

    Facebook Twitter Instagram

    BourseWatch

    • All News
    • Economy
    • List & Ranking
    • Market
    • News

    Recent Post

    • im 24678380
      Here are some reasons why this unpopular stock market technique might work now that trade agreements are being finalized.
    • im 51745889
      How Bessent clarified the euphoric market reaction to the 115-point drop in U.S.-China tariffs
    • im 38580764
      This is the difference in weight loss between Zepbound and Wegovy.

    Subscribe to Updates

    Get the latest creative news from BourseWatch

    © Boursewatch. Designed by Asad Rizvi

    • Privacy Policy
    • Terms
    • Contact Us

    Type above and press Enter to search. Press Esc to cancel.